Results 131 to 140 of about 41,807 (210)

Incidence and risk factors of adverse drug reactions in multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) regimens containing new drugs: a retrospective study of two national multicenter cohorts. [PDF]

J Thorac Dis
Wang Y, Fu L, Li Z, Liu Y, Li L.
europepmc   +1 more source

Optimizing drug-resistant tuberculosis diagnosis: cost-effectiveness of rapid molecular and phenotypic assays in South Africa. [PDF]

BMC Med
Fekadu G, Tolossa T, Gao L, Tola HH, Feyissa TR, Yang L, Chen S, Chaiyakunapruk N, Asfaw E, Siegel M, Ming WK.   +10 more
europepmc   +1 more source

Molecular Characterization and Clonal Analysis of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: Insights Into Biofilm-Related Gene Coexistence in Clinical Isolates. [PDF]

Biomed Res Int
Hadadi M, Esfahani BN, Mirzaei A, Moghim S.   +3 more
europepmc   +1 more source

A historical budget impact and expenditure analysis of meropenem and clavulanate-based treatment for adults with XDR-TB at a specialised TB hospital in South Africa. [PDF]

S Afr Fam Pract (2004)
Mgoqi BB, McGee SA, Suleman F.
europepmc   +1 more source

Exploring Novel Gene Mutations Associated with Fluoroquinolone Resistance in <i>Mycobacterium tuberculosis</i>: Gene Sequencing Results from 275 Clinical Isolates in Chongqing, China. [PDF]

Infect Drug Resist
Zheng X, Zhou T, Zeng R, Lu Y, Yang S, Ouyang J, Xu J, Yu J, Deng J, Chen Y.   +9 more
europepmc   +1 more source

Genomic characterisation of extensively drug-resistant Acinetobacter baumannii isolates from a tertiary hospital in Ghana. [PDF]

PLoS One
Ashley-Agbedor IE, Mahazu S, Kotey FCN, Amedior J, Adu B, Darko E, Kwao P, Dayie NTKD, Ablordey AS, Opintan JA.   +9 more
europepmc   +1 more source

Implementing shorter all-oral treatment durations for multidrug-resistant tuberculosis in the UK: from concept to application. [PDF]

BMJ Open Respir Res
Chavda A, Gilchrist M, Capstick T, Chen C, Kon OM.   +4 more
europepmc   +1 more source

Interim Effectiveness and Safety of Prolonged Bedaquiline Use in Comparison to Standard 24-Week Treatment for MDR-TB: A Multicenter Cohort Study in China. [PDF]

Infect Drug Resist
Hu X, Gao M, Liu Y, Pei Y, Du J, Wu G, Wang A, Li L, Gao J.   +8 more
europepmc   +1 more source

XDR-TB, extensively drug-resistant tuberculosis

Biomédica, 2007
openaire   +5 more sources

Clinical Characteristics and Resistance Patterns of Extensively Drug-Resistant <i>Salmonella Typhi</i> in the Pediatric Population of Pakistan: A Prospective Study. [PDF]

Sage Open Pediatr
Khalid H, Rehman Z, Muhammad Kabir M, Razaq N, Riaz K, Afnan Z, Dawood Nazir M, Binashikhbubkr NK.   +7 more
europepmc   +1 more source